You are seeing these quotes based on previous browsing related to sectors such as
Latest | Forecast | |
---|---|---|
Div Yield | 0.0% | n/a |
Div Cover | n/a | n/a |
Op Mrgn | -1,293.5% | n/a |
ROCE | 0.0% |
Latest | Forecast | |
---|---|---|
P/E | -0.3 | n/a |
PEG | 0.0 | n/a |
Price / Revenue | 8.1 | n/a |
Price / Book value | -2.4 |
Latest | Forecast | |
---|---|---|
Revenue | -32.7% | 0.0% |
PBT | 0.0% | n/a |
EPS | 0.0% | 0.0% |
DPS | n/a | 0.0% |
Year Ending | Revenue ($m) |
Pre-tax ($m) |
EPS | P/E | PEG | EPS Growth | Div | Yield |
---|---|---|---|---|---|---|---|---|
2020-06-30 | n/a | -10.61 | $-0.16 | -41.1 | 0.0 | n/a | n/a | 0.0% |
2021-06-30 | 1.49 | -35.79 | $-0.43 | -34.7 | 0.0 | n/a | n/a | 0.0% |
2022-06-30 | 2.97 | -49.63 | $-0.78 | -1.6 | 0.0 | n/a | n/a | 0.0% |
2023-06-30 | 3.40 | -45.60 | $-0.55 | -2.6 | 0.0 | n/a | n/a | 0.0% |
2024-06-30 | 2.29 | -33.45 | $-0.31 | -0.4 | 0.0 | n/a | n/a | 0.0% |
Renalytix terminates formal sale process Sharecast News | 20 Aug |
---|---|
Renalytix test gets US Medicare coverage determination Sharecast News | 14 Jun |
Renalytix surges on takeover approach Sharecast News | 04 Mar |
Audited Full Year Fiscal 2024 Results | 21-Nov-24 07:01 |
---|---|
Financial Results for Q1 of Fiscal Year 2025 | 20-Nov-24 07:02 |
Holding(s) in Company | 08-Nov-24 09:32 |
Holding(s) in Company | 07-Nov-24 16:35 |
Holding(s) in Company | 07-Nov-24 13:20 |